Stephen J. Gange focuses on Immunology, Internal medicine, Acquired immunodeficiency syndrome, Cohort study and Viral load. The various areas that he examines in his Immunology study include Incidence and Virology. His Acquired immunodeficiency syndrome study combines topics from a wide range of disciplines, such as Young adult, Longitudinal study, Mortality rate and Cohort.
In his research on the topic of Mortality rate, Public health and Epidemiology is strongly related with Life expectancy. His Cohort study research integrates issues from Gerontology and MEDLINE. Stephen J. Gange interconnects Subclinical infection and Multicenter AIDS Cohort Study in the investigation of issues within Viral load.
Stephen J. Gange mainly focuses on Immunology, Internal medicine, Acquired immunodeficiency syndrome, Cohort study and Cohort. His is involved in several facets of Immunology study, as is seen by his studies on Viral load, Viral disease, Women's Interagency HIV Study, Lentivirus and Multicenter AIDS Cohort Study. Internal medicine is closely attributed to Gastroenterology in his research.
His Acquired immunodeficiency syndrome research includes themes of Prospective cohort study, Epidemiology, Gerontology and Immunopathology. His studies in Cohort study integrate themes in fields like Young adult, Incidence and Risk factor. His research on Cohort frequently links to adjacent areas such as Disease.
His main research concerns Cohort, Internal medicine, Immunology, Women's Interagency HIV Study and Acquired immunodeficiency syndrome. His Cohort research is multidisciplinary, relying on both Antiretroviral therapy, Epidemiology, Cohort study and Confidence interval. His Internal medicine research focuses on Gastroenterology and how it relates to Monocyte.
His biological study spans a wide range of topics, including Liver disease, Subclinical infection and Gene. His Acquired immunodeficiency syndrome research incorporates elements of Cancer, Interquartile range, Poisson regression, Gerontology and Viral load. His Viral load study integrates concerns from other disciplines, such as Young adult and Polymorphism.
His scientific interests lie mostly in Cohort, Internal medicine, Acquired immunodeficiency syndrome, Cohort study and Immunology. His studies deal with areas such as Incidence, Confidence interval, Esophageal candidiasis, Antiretroviral therapy and Survival analysis as well as Cohort. His work on Proportional hazards model and Mortality rate as part of general Internal medicine research is often related to Weight gain, thus linking different fields of science.
His Acquired immunodeficiency syndrome research incorporates themes from Interquartile range and Poisson regression. Stephen J. Gange usually deals with Cohort study and limits it to topics linked to Myocardial infarction and Abacavir, MEDLINE, Risk factor and Disease. Stephen J. Gange has researched Immunology in several fields, including Gastroenterology and Relative risk.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Latent infection of CD4 + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
Diana Finzi;Joel N Blankson;Janet M Siliciano;Joseph Bernard Margolick.
Nature Medicine (1999)
Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States
Denise L. Jacobson;Stephen J. Gange;Noel R. Rose;Neil M.H. Graham.
Clinical Immunology and Immunopathology (1997)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.
Janet D Siliciano;Joleen Kajdas;Diana Finzi;Thomas C Quinn;Thomas C Quinn.
Nature Medicine (2003)
Effect of early versus deferred antiretroviral therapy for HIV on survival.
Mari M. Kitahata;Stephen J. Gange;Alison G. Abraham;Barry Merriman.
The New England Journal of Medicine (2009)
Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.
Hasina Samji;Angela Cescon;Robert S. Hogg;Robert S. Hogg;Sharada P. Modur.
PLOS ONE (2013)
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection
Raj Shankarappa;Joseph B. Margolick;Stephen J. Gange;Allen G. Rodrigo.
Journal of Virology (1999)
Competing Risk Regression Models for Epidemiologic Data
Bryan Lau;Stephen R. Cole;Stephen J. Gange.
American Journal of Epidemiology (2009)
Association between Adherence to Antiretroviral Therapy and Human Immunodeficiency Virus Drug Resistance
Ajay K. Sethi;David D. Celentano;Stephen J. Gange;Richard D. Moore;Richard D. Moore.
Clinical Infectious Diseases (2003)
The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.
Melanie C. Bacon;Viktor von Wyl;Christine Alden;Gerald Sharp.
Clinical and Vaccine Immunology (2005)
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
J. B. Dinoso;S. Y. Kim;A. M. Wiegand;S. E. Palmer;S. E. Palmer.
Proceedings of the National Academy of Sciences of the United States of America (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: